摇尾乞怜 发表于 2025-3-21 19:44:38

书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient影响因子(影响力)<br>        http://impactfactor.cn/2024/if/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient影响因子(影响力)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient网络公开度<br>        http://impactfactor.cn/2024/at/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient网络公开度学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient被引频次<br>        http://impactfactor.cn/2024/tc/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient被引频次学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient年度引用<br>        http://impactfactor.cn/2024/ii/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient年度引用学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient读者反馈<br>        http://impactfactor.cn/2024/5y/?ISSN=BK0239925<br><br>        <br><br>书目名称Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient读者反馈学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=BK0239925<br><br>        <br><br>

bourgeois 发表于 2025-3-21 20:17:26

http://reply.papertrans.cn/24/2400/239925/239925_2.png

态度暖昧 发表于 2025-3-22 03:05:03

http://reply.papertrans.cn/24/2400/239925/239925_3.png

误传 发表于 2025-3-22 07:37:17

Carola Pantenburg,Gerhard Peterns. Prompt recognition and management of these complications are imperative to achieve the best possible outcomes. The optimal screening regimen for cardiac complications has yet to be established, but there are promising new biomarkers and imaging modalities that may aid in more prompt diagnosis and intervention in the future.

方舟 发表于 2025-3-22 09:12:11

http://reply.papertrans.cn/24/2400/239925/239925_5.png

浮雕 发表于 2025-3-22 14:06:15

http://reply.papertrans.cn/24/2400/239925/239925_6.png

浮雕 发表于 2025-3-22 17:41:35

http://reply.papertrans.cn/24/2400/239925/239925_7.png

Interdict 发表于 2025-3-22 23:26:50

http://reply.papertrans.cn/24/2400/239925/239925_8.png

庄严 发表于 2025-3-23 01:42:52

http://reply.papertrans.cn/24/2400/239925/239925_9.png

MURKY 发表于 2025-3-23 05:51:12

Cardiac Dysfunction in Hematology Oncology and Hematopoietic Cell Transplant Patientsns. Prompt recognition and management of these complications are imperative to achieve the best possible outcomes. The optimal screening regimen for cardiac complications has yet to be established, but there are promising new biomarkers and imaging modalities that may aid in more prompt diagnosis and intervention in the future.
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient; An Evidence-Based Gu Christine N. Duncan,Julie-An M. Talano,J